Literature DB >> 23929614

Should anyone still be taking simvastatin 80 mg?

Upasana Tayal1, Richard Carroll.   

Abstract

A 64-year-old woman who previously suffered myalgia with lower dose simvastatin was given just one high dose of simvastatin and developed rhabdomyolysis. This was a potentially life-threatening complication. Fortunately she recovered with conservative management and did not require haemofiltration. This case reminds us of the risks of statins and the caution that needs to be exercised when prescribing these medications to patients with a history of intolerances.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23929614      PMCID: PMC3762409          DOI: 10.1136/bcr-2013-200415

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  7 in total

1.  The risk for significant creatine kinase elevation with statins.

Authors:  Ryan S Stolcpart; Kari L Olson; Thomas Delate; Jon Rasmussen; Thomas F Rehring; John A Merenich
Journal:  Am J Cardiovasc Drugs       Date:  2010       Impact factor: 3.571

2.  Statin-associated rhabdomyolysis: is there a dose-response relationship?

Authors:  Anne Holbrook; Mitchell Wright; Melani Sung; Christine Ribic; Steven Baker
Journal:  Can J Cardiol       Date:  2011 Mar-Apr       Impact factor: 5.223

3.  Daily and intermittent rosuvastatin 5 mg therapy in statin intolerant patients: an observational study.

Authors:  Claire Meek; Anthony S Wierzbicki; Christina Jewkes; Patrick J Twomey; Martin A Crook; Alan Jones; Adie Viljoen
Journal:  Curr Med Res Opin       Date:  2012-02-07       Impact factor: 2.580

4.  Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy.

Authors:  Matthew Silva; Michele L Matthews; Courtney Jarvis; Nicole M Nolan; Paul Belliveau; Michael Malloy; Pritesh Gandhi
Journal:  Clin Ther       Date:  2007-02       Impact factor: 3.393

Review 5.  Intermittent nondaily dosing strategies in patients with previous statin-induced myopathy.

Authors:  Alyssa J Keating; Kristen Bova Campbell; John R Guyton
Journal:  Ann Pharmacother       Date:  2013-03-12       Impact factor: 3.154

6.  The safety of rosuvastatin in comparison with other statins in over 100,000 statin users in UK primary care.

Authors:  Luis Alberto García-Rodríguez; Elvira Luján Massó-González; Mari-Ann Wallander; Saga Johansson
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-10       Impact factor: 2.890

7.  Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial.

Authors:  Jane Armitage; Louise Bowman; Karl Wallendszus; Richard Bulbulia; Kazem Rahimi; Richard Haynes; Sarah Parish; Richard Peto; Rory Collins
Journal:  Lancet       Date:  2010-11-08       Impact factor: 79.321

  7 in total
  3 in total

Review 1.  Reducing the Burden of Diabetes Treatment: A Review of Low-cost Oral Hypoglycemic Medications.

Authors:  Elizabeth M Vaughan; Jaime J Rueda; Susan L Samson; David J Hyman
Journal:  Curr Diabetes Rev       Date:  2020

2.  Acute rhabdomyolysis associated with coadministration of levofloxacin and simvastatin in a patient with normal renal function.

Authors:  Maria Paparoupa; Sebastian Pietrzak; Adrian Gillissen
Journal:  Case Rep Med       Date:  2014-07-22

3.  A meta-analysis of red yeast rice: an effective and relatively safe alternative approach for dyslipidemia.

Authors:  Yinhua Li; Long Jiang; Zhangrong Jia; Wei Xin; Shiwei Yang; Qiu Yang; Luya Wang
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.